Find a Viewpoint

Antimicrobial Viewpoints are articles in which experts in different areas of antimicrobial resistance share their knowledge and opinions about the current status and the future challenges of this field. You can read our editorial and ethics policies for these articles here

<br>The non-profit future of antibacterial R&D</br><em> – by Brad Spellberg</em>
28 January 2022

The non-profit future of antibacterial R&D – by Brad Spellberg

more
<br>One-health approach: Can antifungal resistance arise in the environment?</br><em> – by Rafael W. Bastos and Gustavo H. Goldman</em>
23 November 2021

One-health approach: Can antifungal resistance arise in the environment? – by Rafael W. Bastos and Gustavo H. Goldman

more
<br>Addressing antimicrobial resistance for better care in cancer patients</br><em> – by Yehoda M. Martei and Shalini J. Zürn</em>
24 September 2021

Addressing antimicrobial resistance for better care in cancer patients – by Yehoda M. Martei and Shalini J. Zürn

more
<br>Trials of COVID-19 vaccines: what can be learnt for the development of new antimicrobials?</br><em> – by Stephen Senn</em>
13 August 2021

Trials of COVID-19 vaccines: what can be learnt for the development of new antimicrobials? – by Stephen Senn

more
<br>Strengthening the regulation of antimicrobial use to mitigate drug resistance</br><em> – by Maarten van der Heijden</em>
16 July 2021

Strengthening the regulation of antimicrobial use to mitigate drug resistance – by Maarten van der Heijden

more
<br>Addressing the knowledge gaps surrounding AMR infections in neonatal sepsis</br><em> – by Phoebe Williams, Nina Putri and Gayana Gunaratna</em>
17 June 2021

Addressing the knowledge gaps surrounding AMR infections in neonatal sepsis – by Phoebe Williams, Nina Putri and Gayana Gunaratna

more

Share

FacebookTwitterRedditLinkedInEmail
✕

Newsletter

Subscribe to our newsletter to stay up-to-date about our webinars, conferences and other activities.



View previous newsletter

Go to Top